Heme oxygenase‐1 alleviates allergic airway inflammation by suppressing NF‐κB ‐mediated pyroptosis of bronchial epithelial cells
The FASEB Journal · 15.02.2024 · 38 (3)
DOI: 10.1096/fj.202300883rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 08.02.2024. Verfasst von Jiajia Lv und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Asthma, Heme Oxygenase-1, NF-kappa B. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), the Innovative Research Team of High-Level Local Universities in Shanghai, startup fund of Wenzhou Institute, University of Chinese Academy of Sciences.
Abstract (Originalsprache)
Allergic asthma development and pathogenesis are influenced by airway epithelial cells in response to allergens. Heme oxygenase‐1 (HO‐1), an inducible enzyme responsible for the breakdown of heme, has been considered an appealing target for the treatment of chronic inflammatory diseases. Herein, we report that alleviation of allergic airway inflammation by HO‐1‐mediated suppression of pyroptosis in airway epithelial cells (AECs). Using house dust mite (HDM)‐induced asthma models of mice, we found increased gasdermin D (GSDMD) in the airway epithelium. In vivo administration of disulfiram, a specific inhibitor of pore formation by GSDMD, decreased thymic stromal lymphopoietin (TSLP) release, T helper type 2 immune response, alleviated airway inflammation, and reduced airway hyperresponsiveness (AHR). HO‐1 induction by hemin administration reversed these phenotypes. In vitro studies revealed that HO‐1 restrained GSDMD‐mediated pyroptosis and cytokine TSLP release in AECs by binding Nuclear Factor‐Kappa B (NF‐κB) p65 RHD domain and thus controlling NF‐κB‐dependent pyroptosis. These data provide new therapeutic indications for purposing HO‐1 to counteract inflammation, which contributes to allergic inflammation control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Pulmonary, Children's Hospital of Soochow University, Suzhou, China.
- Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, China.
ORCID-Profile: Jiajia Lv, Yao Zhou, Jing Wang, Yujiao Wu, Qianying Yu, Meng Zhang, Wen Su, Zhiwei Tang, Qun Wu, Min Wu, Zhenwei Xia
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- the Innovative Research Team of High-Level Local Universities in Shanghai
- startup fund of Wenzhou Institute, University of Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Lv, J., Zhou, Y., Wang, J., Wu, Y., Yu, Q., Zhang, M., Su, W., Tang, Z., Wu, Q., Wu, M., & Xia, Z. (2024). Heme oxygenase‐1 alleviates allergic airway inflammation by suppressing NF‐κB ‐mediated pyroptosis of bronchial epithelial cells. The FASEB Journal, 38(3). https://doi.org/10.1096/fj.202300883rr
Vancouver
Lv J, Zhou Y, Wang J, Wu Y, Yu Q, Zhang M, et al. Heme oxygenase‐1 alleviates allergic airway inflammation by suppressing NF‐κB ‐mediated pyroptosis of bronchial epithelial cells. The FASEB Journal. 2024;38(3). doi:10.1096/fj.202300883rr
BibTeX
@article{Lv2024,
author = {Lv, Jiajia and Zhou, Yao and Wang, Jing and Wu, Yujiao and Yu, Qianying and Zhang, Meng and Su, Wen and Tang, Zhiwei and Wu, Qun and Wu, Min and Xia, Zhenwei},
title = {Heme oxygenase‐1 alleviates allergic airway inflammation by suppressing NF‐κB ‐mediated pyroptosis of bronchial epithelial cells},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {3},
doi = {10.1096/fj.202300883rr}
}
EUVIMED